Orleans Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-3,817
| Closed | -$427K | – | 87 |
|
|
2021
Q4 | $427K | Sell |
3,817
-1,637
| -30% | -$183K | 0.24% | 64 |
|
|
2021
Q3 | $686K | Sell |
5,454
-12,456
| -70% | -$1.57M | 0.44% | 50 |
|
|
2021
Q2 | $2.43M | Buy |
17,910
+970
| +6% | +$131K | 1.55% | 30 |
|
|
2021
Q1 | $2.3M | Hold |
16,940
| – | – | 1.56% | 27 |
|
|
2020
Q4 | $2.39M | Buy |
16,940
+1,105
| +7% | +$156K | 1.71% | 25 |
|
|
2020
Q3 | $1.76M | Buy |
15,835
+3,650
| +30% | +$407K | 1.35% | 33 |
|
|
2020
Q2 | $1.36M | Buy |
+12,185
| New | +$1.36M | 1.11% | 37 |
|